News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
The association of oncogene driver mutations with recurrence and survival in stage I NSCLC
Daniel M. Libby
Dec 25, 2024, 09:42

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

Clinical Lung Cancer shared an article by Daniel M. Libby on X:

“Explore a new article evaluating the association of oncogene driver mutations with recurrence and survival in stage I non-small cell lung cancer (NSCLC).”

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Non-small Cell Lung Cancer.

Authors: Daniel M. Libby, et al.

The association of oncogene driver mutations with recurrence and survival in stage I NSCLC

cancer Clinical Lung Cancer Daniel M. Libby fight against cancer Global fight against cancer non small cell lung cancer NSCLC OncoDaily oncogene Oncology
Special Coverage
Science
Dec 25, 2024, 09:42
The association of oncogene driver mutations with recurrence and survival in stage I NSCLC
Science
Dec 25, 2024, 09:30
Susanna Greer: Research helps us make changes today that impact our future cancer risks
Blog
Dec 25, 2024, 09:23
Christian Ntizimira: Exciting progress in palliative care across Rwanda
Science
Dec 25, 2024, 09:10
Greg J. Fox: Levofloxacin's safety for preventing multidrug-resistant TB
Blog
Dec 25, 2024, 09:00
The Babak Lab: Professor Wee Han Ang on Mentorship, Research and Balance
Blog
Dec 25, 2024, 08:51
Finding Strength in Community: The Power of a Tribe on the Cancer Journey - Judy Medeiros Fitzgerald
Insight
Dec 25, 2024, 03:51
Maria Babak: Critical advancement in the treatment of mCSCC and laCSCC
Science
Dec 25, 2024, 03:40
The effect of exercise in aiding cancer treatment and mitigating the treatment side-effects, suggested by Christopher Fitzmaurice
Blog
Dec 25, 2024, 03:35
Amol Akhade: Use of Dostarlimab plus niraparib in first line Advanced Ovarian Cancer
Insight
Dec 25, 2024, 03:32
Optimising Cancer Care for Older Adults - MASCC
Insight
Dec 25, 2024, 03:00
Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh
Insight
Dec 25, 2024, 02:57
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC